Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Indikationer for radioimmunterapi til patienter med non-Hodgkins lymfom

Research output: Contribution to journalJournal article

  1. Verbal og Oral Dyspraksi hos børn og unge

    Research output: Contribution to journalJournal article

  2. Diagnostik af udviklingsmæssig dyspraksi

    Research output: Contribution to journalJournal article

  3. Første danske patient med et genkendeligt genetisk KBG-syndrom

    Research output: Contribution to journalJournal article

  4. Diagnostik og behandling af migræne hos børn og unge

    Research output: Contribution to journalJournal article

  5. Oral og verbal dyspraksi hos en i øvrigt rask pige

    Research output: Contribution to journalJournal article

View graph of relations
Translated title of the contributionIndications for radioimmunotherapy for patients with non-Hodgkin's lymphoma
Radioimmunotherapy is a well-known treatment for non-Hodgkin's lymphoma. (90)yttrium (Y)-ibritumomab-tiuxetan consists of a radioisotope conjugated to a monoclonal anti-cluster of differentiation 20 antibody, which is targeted against B-lymphocytes. Initially the treatment indication was relapse of low-grade non-Hodgkin's lymphoma. However, (90)Y-ibritumomab-tiuxetan has later been used in clinical trials in the treatment of other types of non-Hodgkin's lymphoma and prior to stem cell transplantation. Based on the literature this systematic review aims to throw light on the future possibilities of radioimmunotherapy.
Original languageDanish
JournalUgeskrift for Laeger
Volume173
Issue number20
Pages (from-to)1417-21
Number of pages5
ISSN0041-5782
StatePublished - 2011

ID: 34579273